天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

Home Cart 0 Sign in  

[ CAS No. 1129634-44-1 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 1129634-44-1
Chemical Structure| 1129634-44-1
Structure of 1129634-44-1 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 1129634-44-1 ]

Related Doc. of [ 1129634-44-1 ]

Alternatived Products of [ 1129634-44-1 ]
Product Citations

Product Details of [ 1129634-44-1 ]

CAS No. :1129634-44-1 MDL No. :MFCD11099673
Formula : C12H19NO4 Boiling Point : -
Linear Structure Formula :- InChI Key :-
M.W : 241.28 Pubchem ID :-
Synonyms :

Calculated chemistry of [ 1129634-44-1 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 17
Num. arom. heavy atoms : 0
Fraction Csp3 : 0.83
Num. rotatable bonds : 4
Num. H-bond acceptors : 4.0
Num. H-bond donors : 1.0
Molar Refractivity : 65.6
TPSA : 66.84 ?2

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.72 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.31
Log Po/w (XLOGP3) : 1.48
Log Po/w (WLOGP) : 1.42
Log Po/w (MLOGP) : 1.31
Log Po/w (SILICOS-IT) : 0.76
Consensus Log Po/w : 1.46

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -2.0
Solubility : 2.39 mg/ml ; 0.0099 mol/l
Class : Soluble
Log S (Ali) : -2.49
Solubility : 0.78 mg/ml ; 0.00323 mol/l
Class : Soluble
Log S (SILICOS-IT) : -0.92
Solubility : 29.3 mg/ml ; 0.122 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 3.25

Safety of [ 1129634-44-1 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 1129634-44-1 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 1129634-44-1 ]

[ 1129634-44-1 ] Synthesis Path-Downstream   1~2

  • 1
  • [ 1129634-44-1 ]
  • [ 66521-66-2 ]
  • C21H25N5O3 [ No CAS ]
YieldReaction ConditionsOperation in experiment
44% The solution of (S)-5-(tert-butoxycarbonyl)-5-azaspiro[2.4]heptane-6-carboxylicacid (2.0 g, 8.5 mmol) and NMI (2.1 g, 25.5 mmol) in DMF (20 mL), cooled to 0 oC,was added by MsCl (978 mg, 8.5 mmol) dropwise, and kept stirring for 15min. Then <strong>[66521-66-2]4-(pyridin-3-yl)pyrimidin-2-amine</strong> (980 mg, 5.7 mmol) was added,followed by addition of lithium chloride (721 mg, 17.0 mmol). The reaction wasstirred at rt and monitored by TLC. After 48 h, the mixture was diluted by EA,washed by 10% citric acid, and extracted by EA (2x50 mL). The combined organiclayers were washed by saturated Na2CO3 solution and brine.Concentration under reduced pressure gave the crude, which was purified bysilica gel (DCM/MeOH = 100/1 to 30/1) to get the pure product (1.0 g, 44%yield).1H NMR(400 MHz, CDCl3) (two rotomers were observed) delta 9.98 (brs, 0.5H),9.28 (d, J = 2.0 Hz, 1H), 9.06 (brs, 0.5H),8.83-8.70 (m, 2H), 8.42 (d, J = 8.0Hz, 1H), 7.56-7.40 (m, 2H), 4.96-4.60 (m, 1H), 3.65-3.50 (m, 1H), 3.45-3.10 m, 1H),2.50-2.25 (m, 1H), 2.20-2.05 (m, 1H), 1.51 (s, 9H), 0.78-0.54 (s, 4H).
44% (S)-5-(tert-butoxycarbonyl)-5-azaspiro[2.4]heptane-6-carboxylic acid (2.0 g, 8.5 mmol) was dissolved in DMF (20 mL), followed by the addition of NMI (2.1 g, 25.5 mmol). The mixture was cooled to 0 C, into which MsCl (978 mg, 8.5 mmol) was added dropwise. The mixture was stirred for 15 min. Then 4-(3-pyridyl)pyrimidin-2-amine (980 mg, 5.7 mmol) and lithium chloride (721 mg, 17.0 mmol) were added. After reacting at room temperature for 48 hours under stirring, the reaction mixture was diluted with ethyl acetate, and washed with 10% citric acid aqueous solution. The aqueous phase was extracted with ethyl acetate (2x50 mL). The organic phase was washed with saturated sodium carbonate and sodium chloride. After concentrating under reduced pressure, pure product (1.0g, 44% yield) was obtained by the purification of the crude product through silica gel column (DCM/MeOH = 100/1-30/1). 1H NMR (400 MHz, CDCl3) (two rotomers were observed) delta 9.98 (brs, 0.5H), 9.28 (d, J = 2.0 Hz, 1H), 9.06 (brs, 0.5H), 8.83-8.70 (m, 2H), 8.42 (d, J = 8.0 Hz, 1H), 7.56-7.40 (m, 2H), 4.96-4.60 (m, 1H), 3.65-3.50 (m, 1H), 3.45-3.10 m, 1H), 2.50-2.25 (m, 1H), 2.20-2.05 (m, 1H), 1.51 (s, 9H), 0.78-0.54 (s, 4H).
  • 2
  • [ 1129634-44-1 ]
  • [ 66521-66-2 ]
  • C16H17N5O*ClH [ No CAS ]
Recommend Products
Same Skeleton Products

Technical Information

Historical Records

Similar Product of
[ 1129634-44-1 ]

Chemical Structure| 1441673-92-2

A101613[ 1441673-92-2 ]

Potassium (S)-5-(tert-butoxycarbonyl)-5-azaspiro[2.4]heptane-6-carboxylate

Reason: Free-Salt

Related Functional Groups of
[ 1129634-44-1 ]

Amides

Chemical Structure| 1441673-92-2

[ 1441673-92-2 ]

Potassium (S)-5-(tert-butoxycarbonyl)-5-azaspiro[2.4]heptane-6-carboxylate

Similarity: 0.98

Chemical Structure| 197142-34-0

[ 197142-34-0 ]

(1R,3S,5R)-2-(tert-Butoxycarbonyl)-2-azabicyclo[3.1.0]hexane-3-carboxylic acid

Similarity: 0.98

Chemical Structure| 1217525-04-6

[ 1217525-04-6 ]

(2R)-1-(tert-Butoxycarbonyl)octahydro-1H-indole-2-carboxylic acid

Similarity: 0.98

Chemical Structure| 291775-59-2

[ 291775-59-2 ]

(1R,3S,4S)-2-(tert-Butoxycarbonyl)-2-azabicyclo[2.2.1]heptane-3-carboxylic acid

Similarity: 0.95

Chemical Structure| 98303-20-9

[ 98303-20-9 ]

1-(tert-Butoxycarbonyl)piperidine-2-carboxylic acid

Similarity: 0.92

Carboxylic Acids

Chemical Structure| 197142-34-0

[ 197142-34-0 ]

(1R,3S,5R)-2-(tert-Butoxycarbonyl)-2-azabicyclo[3.1.0]hexane-3-carboxylic acid

Similarity: 0.98

Chemical Structure| 1217525-04-6

[ 1217525-04-6 ]

(2R)-1-(tert-Butoxycarbonyl)octahydro-1H-indole-2-carboxylic acid

Similarity: 0.98

Chemical Structure| 291775-59-2

[ 291775-59-2 ]

(1R,3S,4S)-2-(tert-Butoxycarbonyl)-2-azabicyclo[2.2.1]heptane-3-carboxylic acid

Similarity: 0.95

Chemical Structure| 98303-20-9

[ 98303-20-9 ]

1-(tert-Butoxycarbonyl)piperidine-2-carboxylic acid

Similarity: 0.92

Chemical Structure| 159749-28-7

[ 159749-28-7 ]

1-(tert-Butoxycarbonyl)azetidine-2-carboxylic acid

Similarity: 0.90

Related Parent Nucleus of
[ 1129634-44-1 ]

Pyrrolidines

Chemical Structure| 1441673-92-2

[ 1441673-92-2 ]

Potassium (S)-5-(tert-butoxycarbonyl)-5-azaspiro[2.4]heptane-6-carboxylate

Similarity: 0.98

Chemical Structure| 175526-97-3

[ 175526-97-3 ]

1-Boc-3-Pyrrolidineacetic acid

Similarity: 0.84

Chemical Structure| 117625-90-8

[ 117625-90-8 ]

1-Boc-2-Formylpyrrolidine

Similarity: 0.84

Chemical Structure| 204688-61-9

[ 204688-61-9 ]

(S)-2-(1-(tert-Butoxycarbonyl)pyrrolidin-3-yl)acetic acid

Similarity: 0.84

Chemical Structure| 204688-60-8

[ 204688-60-8 ]

(R)-2-(1-Boc-3-pyrrolidinyl)acetic Acid

Similarity: 0.84

Spiroes

Chemical Structure| 1441673-92-2

[ 1441673-92-2 ]

Potassium (S)-5-(tert-butoxycarbonyl)-5-azaspiro[2.4]heptane-6-carboxylate

Similarity: 0.98

Chemical Structure| 1352882-80-4

[ 1352882-80-4 ]

2-(tert-Butoxycarbonyl)-2-azaspiro[5.5]undecane-9-carboxylic acid

Similarity: 0.78

Chemical Structure| 871727-05-8

[ 871727-05-8 ]

6-(tert-Butoxycarbonyl)-6-azaspiro[2.5]octane-1-carboxylic acid

Similarity: 0.78

Chemical Structure| 849928-23-0

[ 849928-23-0 ]

2-(((9H-Fluoren-9-yl)methoxy)carbonyl)-8-(tert-butoxycarbonyl)-2,8-diazaspiro[4.5]decane-3-carboxylic acid

Similarity: 0.78

Chemical Structure| 1357354-49-4

[ 1357354-49-4 ]

2-tert-Butyl 9-ethyl 2,7-diazaspiro[4.4]nonane-2,9-dicarboxylate

Similarity: 0.74

; ;